Skip to content
healthcare.dev

Topiramate

NDC 27808-325, Topiramate, capsule, extended release, from Cranbury Pharmaceuticals, LLC.

Product NDC
27808-325
Status
Listed
Labeler
Cranbury Pharmaceuticals, LLC
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218695
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/27808-325 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOPIRAMATE25 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
27808-325-012780803250130 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (27808-325-01)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8d5f9f77-403e-432a-8dcb-7995c6947ae0

Use it

Look up 27808-325 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/27808-325 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 27808-325. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.